TD Cowen Initiates Rapid Micro Biosystems(RPID.US) With Buy Rating
Morgan Stanley Remains a Hold on Rapid Micro Biosystems (RPID)
Morgan Stanley Maintains Rapid Micro Biosystems(RPID.US) With Hold Rating, Cuts Target Price to $1.5
TD Cowen Maintains Rapid Micro Biosystems(RPID.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Rapid Micro Biosystems (RPID), COMPASS Pathways (CMPS) and Harrow Health (HROW)
TD Cowen Sticks to Its Buy Rating for Rapid Micro Biosystems (RPID)
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Fastenal Company (FAST) and Rapid Micro Biosystems (RPID)
Analysts Conflicted on These Industrial Goods Names: Austal Limited (OtherAUTLF) and Rapid Micro Biosystems (RPID)
Analysts Conflicted on These Industrial Goods Names: Austal Limited (OtherAUTLF) and Rapid Micro Biosystems (RPID)
Analysts Offer Insights on Industrial Goods Companies: Austal Limited (OtherAUTLF), Rapid Micro Biosystems (RPID) and Hydrofarm Holdings Group (HYFM)
Stifel Nicolaus Sticks to Their Buy Rating for Rapid Micro Biosystems (RPID)
Rapid Micro Biosystems Cut to Neutral From Overweight by JP Morgan
Rapid Micro Biosystems Analyst Ratings
No Data
No Data